Novo Nordisk ADR [NVO] gain 28.63% so far this year. What now?

Novo Nordisk ADR [NYSE: NVO] loss -2.10% or -2.85 points to close at $133.07 with a heavy trading volume of 12691017 shares. The company report on March 8, 2024 at 2:57 PM that Wegovy® receives FDA approval for cardiovascular risk reduction in adults with known